Human cytomegalovirus UL18 utilizes US6 for evading the NK and T-cell responses

PLoS Pathogens

Volumn 4, Issue 8, 2008, Pages

  Kim, Youngkyun ^a   Park, Boyoun ^a   Cho, Sunglim ^a   Shin, Jinwook ^a   Cho, Kwangmin ^a   Jun, Youngsoo ^a   Ahn, Kwangseog ^a  

^a Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; UL18 PROTEIN; UNCLASSIFIED DRUG; US6 PROTEIN; VIRUS GLYCOPROTEIN; CAPSID PROTEIN; CARRIER PROTEIN; HLA ANTIGEN CLASS 1; PEPTIDE; RNA BINDING PROTEIN; TAPASIN; US6 PROTEIN, HUMAN CYTOMEGALOVIRUS; VIRUS PROTEIN; VP23 PROTEIN, HUMAN HERPESVIRUS 1;

ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EMBRYO; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR DYNAMICS; NATURAL KILLER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; T LYMPHOCYTE; VIRUS VIRULENCE; BIOSYNTHESIS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; GENE EXPRESSION REGULATION; HELA CELL; IMMUNOLOGY; METABOLISM; PROTEIN TRANSPORT;

HUMAN HERPESVIRUS 5;

CAPSID PROTEINS; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GENE EXPRESSION REGULATION; HELA CELLS; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; KILLER CELLS, NATURAL; MEMBRANE TRANSPORT PROTEINS; PEPTIDES; PROTEIN TRANSPORT; RNA-BINDING PROTEINS; T-LYMPHOCYTES; VIRAL PROTEINS;

EID: 50849088309     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1000123     Document Type: Article

References (46)

1. Ho M (1990) Epidemiology of cytomegalovirus infections. Rev Infect Dis 12 Suppl. 7: S701-710.
2. Wattre P, Dewilde A, Lobert PE (1995) [Current status of human cytomegalovirus disease]. Rev Med Interne 16: 354-367.
3. Townsend A, Bodmer H (1989) Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 7: 601-624.
4. Elliott T, Williams A (2005) The optimization of peptide cargo bound to MHC class I molecules by the peptide-loading complex. Immunol Rev 207: 89-99.
5. Park B, Lee S, Kim E, Cho K, Riddell SR, et al. (2006) Redox regulation facilitates optimal peptide selection by MHC class I during antigen processing. Cell 127: 369-382.
6. Momburg F, Roelse J, Howard JC, Butcher GW, Hammerling GJ, et al. (1994) Selectivity of MHC-encoded peptide transporters from human, mouse and rat. Nature 367: 648-651.
7. Rock KL, Gramm C, Rothstein L, Clark K, Stein R, et al. (1994) Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 78: 761-771.
8. Androlewicz MJ, Anderson KS, Cresswell P (1993) Evidence that transporters associated with antigen processing translocate a major histocompatibility complex class I-binding peptide into the endoplasmic reticulum in an ATP-dependent manner. Proc Natl Acad Sci U S A 90: 9130-9134.
9. Ahn K, Angulo A, Ghazal P, Peterson PA, Yang Y, et al. (1996) Human cytomegalovirus inhibits antigen presentation by a sequential multistep process. Proc Natl Acad Sci U S A 93: 10990-10995.
10. Hengel H, Koopmann JO, Flohr T, Muranyi W, Goulmy E, et al. (1997) A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. Immunity 6: 623-632.
11. Ahn K, Gruhler A, Galocha B, Jones TR, Wiertz EJ, et al. (1997) The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. Immunity 6: 613-621.
12. Hewitt EW, Gupta SS, Lehner PJ (2001) The human cytomegalovirus gene product US6 inhibits ATP binding by TAP. EMBO J 20: 387-396.
13. Ljunggren HG, Karre K (1990) In search of the 'missing self': MHC molecules and NK cell recognition. Immunol Today 11: 237-244.
14. Cosman D, Mullberg J, Sutherland CL, Chin W, Armitage R, et al. (2001) ULBPs, novel MHC class I-related molecules, bind to CMV glycoprotein UL16 and stimulate NK cytotoxicity through the NKG2D receptor. Immunity 14: 123-133.
15. Reyburn HT, Mandelboim O, Vales-Gomez M, Davis DM, Pazmany L, et al. (1997) The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells. Nature 386: 514-517.
16. Tomasec P, Braud VM, Rickards C, Powell MB, McSharry BP, et al. (2000) Surface expression of HLA-E, an inhibitor of natural killer cells, enhanced by human cytomegalovirus gpUL40. Science 287: 1031.
17. Karre K, Welsh RM (1997) Viral decoy vetoes killer cell. Nature 386: 446-447.
18. Chapman TL, Heikeman AP, Bjorkman PJ (1999) The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18. Immunity 11: 603-613.
19. Beck S, Barrell BG (1988) Human cytomegalovirus encodes a glycoprotein homologous to MHC class-I antigens. Nature 331: 269-272.
20. Wagner CS, Ljunggren HG, Achour A (2008) Immune modulation by the human cytomegalovirus-encoded molecule UL18, a mystery yet to be solved. J Immunol 180: 19-24.
21. Browne H, Smith G, Beck S, Minson T (1990) A complex between the MHC class I homologue encoded by human cytomegalovirus and beta 2 microglobulin. Nature 347: 770-772.
22. Fahnestock ML, Johnson JL, Feldman RM, Neveu JM, Lane WS, et al. (1995) The MHC class I homolog encoded by human cytomegalovirus binds endogenous peptides. Immunity 3: 583-590.
23. Park B, Oh H, Lee S, Song Y, Shin J, et al. (2002) The MHC class I homolog of human cytomegalovirus is resistant to down-regulation mediated by the unique short region protein (US)2, US3, US6, and US11 gene products. J Immunol 168: 3464-3469.
24. Fruh K, Ahn K, Djaballah H, Sempe P, van Endert PM, et al. (1995) A viral inhibitor of peptide transporters for antigen presentation. Nature 375: 415-418.
25. Hill A, Jugovic P, York I, Russ G, Bennink J, et al. (1995) Herpes simplex virus turns off the TAP to evade host immunity. Nature 375: 411-415.
26. Ahn K, Meyer TH, Uebel S, Sempe P, Djaballah H, et al. (1996) Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. EMBO J 15: 3247-3255.
27. Tomazin R, Hill AB, Jugovic P, York I, van Endert P, et al. (1996) Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. EMBO J 15: 3256-3266.
28. Androlewicz MJ, Cresswell P (1994) Human transporters associated with antigen processing possess a promiscuous peptide-binding site. Immunity 1: 7-14.
29. Uebel S, Meyer TH, Kraas W, Kienle S, Jung G, et al. (1995) Requirements for peptide binding to the human transporter associated with antigen processing revealed by peptide scans and complex peptide libraries. J Biol Chem 270: 18512-18516.
30. Maffei M, Ghiotto F, Occhino M, Bono M, De Santanna A, et al. (2008) Human Cytomegalovirus Regulates Surface Expression of the Viral Protein UL18 by Means of Two Motifs Present in the Cytoplasmic Tail. J Immunol 180: 969-979.
31. Leong CC, Chapman TL, Bjorkman PJ, Formankova D, Mocarski ES, et al. (1998) Modulation of natural killer cell cytotoxicity in human cytomegalovirus infection: the role of endogenous class I major histocompatibility complex and a viral class I homolog. J Exp Med 187: 1681-1687.
32. Williams AP, Peh CA, Purcell AW, McCluskey J, Elliott T (2002) Optimization of the MHC class I peptide cargo is dependent on tapasin. Immunity 16: 509-520.
33. Grandea AG 3rd, Golovina TN, Hamilton SE, Sriram V, Spies T, et al. (2000) Impaired assembly yet normal trafficking of MHC class I molecules in Tapasin mutant mice. Immunity 13: 213-222.
34. Garbi N, Tanaka S, Momburg F, Hammerling GJ (2006) Impaired assembly of the major histocompatibility complex class I peptide-loading complex in mice deficient in the oxidoreductase ERp57. Nat Immunol 7: 93-102.
35. Gao B, Adhikari R, Howarth M, Nakamura K, Gold MC, et al. (2002) Assembly and antigen-presenting function of MHC class I molecules in cells lacking the ER chaperone calreticulin. Immunity 16: 99-109.
36. Ortmann B, Copeman J, Lehner PJ, Sadasivan B, Herberg JA, et al. (1997) A critical role for tapasin in the assembly and function of multimeric MHC class ITAP complexes. Science 277: 1306-1309.
37. Park B, Kim Y, Shin J, Lee S, Cho K, et al. (2004) Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. Immunity 20: 71-85.
38. Tortorella D, Gewurz BE, Furman MH, Schust DJ, Ploegh HL (2000) Viral subversion of the immune system. Annu Rev Immunol 18: 861-926.
39. Beersma MF, Bijlmakers MJ, Ploegh HL (1993) Human cytomegalovirus downregulates HLA class I expression by reducing the stability of class I H chains. J Immunol 151: 4455-4464.
40. Garbi N, Tiwari N, Momburg F, Hammerling GJ (2003) A major role for tapasin as a stabilizer of the TAP peptide transporter and consequences for MHC class I expression. Eur J Immunol 33: 264-273.
41. Neisig A, Wubbolts R, Zang X, Melief C, Neefjes J (1996) Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J Immunol 156: 3196-3206.
42. Jun Y, Kim E, Jin M, Sung HC, Han H, et al. (2000) Human cytomegalovirus gene products US3 and US6 down-regulate trophoblast class I MHC molecules. J Immunol 164: 805-811.
43. Wiertz EJ, Jones TR, Sun L, Bogyo M, Geuze HJ, et al. (1996) The human cytomegalovirus US11 gene product dislocates MHC class I heavy chains from the endoplasmic reticulum to the cytosol. Cell 84: 769-779.
44. Cox JH, Yewdell JW, Eisenlohr LC, Johnson PR, Bennink JR (1990) Antigen presentation requires transport of MHC class I molecules from the endoplasmic reticulum. Science 247: 715-718.
45. Andersson M, Paabo S, Nilsson T, Peterson PA (1985) Impaired intracellular transport of class I MHC antigens as a possible means for adenoviruses to evade immune surveillance. Cell 43: 215-222.
46. Fruh K, Yang Y, Arnold D, Chambers J, Wu L, et al. (1992) Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J Biol Chem 267: 22131-22140.